ALTO: Long-term Outcomes of APIPPRA
Dr. Mrinalini Dey interviews Professor Andrew Cope about abstract OP0004, on the long term outcome of APIPPRA patients - the ALTO study, at the EULAR 2025 meeting in Barcelona, Spain.
https://t.co/9wVZSXbi6r https://t.co/fm77qDoTwm
Links:
ALTO: Long-term Outcomes of APIPPRA | RheumNow
https://buff.ly/CNPG3Wz
Jun-20-2025


